boranes has been researched along with bortezomib in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Daniels, JS; Gan, LS; Huang, R; Labutti, J; Miwa, G; Parsons, I | 1 |
| Cheng, L; Cheng, R; Gu, Z; Wang, X; Zhong, Z | 1 |
| Almaguel, F; Das, BC; Das, S; Das, Y; Evans, T; Hosmane, NS; Nandwana, NK; Nandwana, V; Saito, M; Shareef, MA; Weiss, LM | 1 |
1 review(s) available for boranes and bortezomib
| Article | Year |
|---|---|
Boron Chemicals in Drug Discovery and Development: Synthesis and Medicinal Perspective.
Topics: Boranes; Boron; Boron Compounds; Bortezomib; Drug Discovery; Enzyme Inhibitors; Humans | 2022 |
2 other study(ies) available for boranes and bortezomib
| Article | Year |
|---|---|
Oxidative deboronation of the peptide boronic acid proteasome inhibitor bortezomib: contributions from reactive oxygen species in this novel cytochrome P450 reaction.
Topics: Boranes; Boronic Acids; Bortezomib; Chromatography, High Pressure Liquid; Cytochrome P-450 Enzyme System; Humans; Magnetic Resonance Spectroscopy; Mass Spectrometry; Microsomes, Liver; Oxidation-Reduction; Proteasome Inhibitors; Pyrazines; Reactive Oxygen Species | 2006 |
Hyaluronic acid shell and disulfide-crosslinked core micelles for in vivo targeted delivery of bortezomib for the treatment of multiple myeloma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Boranes; Bortezomib; Colloids; Cross-Linking Reagents; Disulfides; Drug Delivery Systems; Hyaluronic Acid; Mice, Nude; Micelles; Multiple Myeloma; Proteasome Inhibitors | 2018 |